Abstract
Objective: To understand the immune landscape of the ovarian cancer (OC) microenvironment and to develop predictive biomarkers to select candidates for immune therapy, we have initiated a study to comprehensively analyze the unique molecular and histopathological characteristics of tumor samples taken during primary debulking and interval debulking and at recurrence.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
